Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Intervention Material Supply

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, titled Intervention Material Supply, involves the provision of drugs, medical devices, and surgical tools to prime contractors supporting DHA and DoD research projects. The selected provider is responsible for manufacturing and delivering interventions that demonstrate proven safety, stability, and dosing consistency. To ensure quality and compliance, the contractor must utilize GMP-certified facilities and maintain ISO 13485 certification for all medical devices. Deliverables include the physical intervention materials accompanied by formal Certificates of Analysis. This opportunity is associated with the Department of the Army USAMRRA under NAICS code 325412.

General Info

Subcontract for GMP-certified medical supplies and devices supporting DHA and DoD research projects.

Agency

Department Of Defense → Department Of The Army -- UsamraaView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of HT942526ORPCRA.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Orthopaedic, Clinical Research Award

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedMay 21

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → Department Of The Army -- Usamraa

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Department Of The Army -- Usamraa

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies drugs, medical devices, or surgical tools for prime contractors on DHA/DoD research projects. Manufactures and delivers interventions with evidence of safety, stability, and dosing consistency. Requires GMP-certified facilities and ISO 13485 for devices. Delivers the physical intervention materials and Certificates of Analysis (CoA).

Similar Contracts

Same NAICS industry code

Supply of Tacrolimus CapsulesThis subcontract involves the supply of Tacrolimus Capsules to prime contractors supporting Department of Veterans Affairs pharmaceutical projects. The selected provider is responsible for manufacturing or sourcing the capsules, assigning a unique National Drug Code, and performing primary labeling. All activities must maintain strict FDA regulatory compliance and ensure that no over-labeling occurs. Logistics are managed through the VA and DoD Pharmaceutical Prime Vendor Programs, with final delivery directed to Prime Vendor distribution centers. This opportunity is associated with NAICS code 325412 and was posted by Nac Pharmaceuticals under the Department of Veterans Affairs.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Tacrolimus Capsules

Solicitation # 36E79726R0033

The Department of Veterans Affairs National Acquisition Center is issuing an unrestricted solicitation under NAICS code 325412 for the procurement of Tacrolimus Capsules. This contract aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a one-year base period with four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item procedures, with a tentative closing date of September 15, 2026. The scope of work includes the supply of three different strengths of Tacrolimus Capsules: 0.5mg, 1mg, and 5mg, with estimated annual quantities of 51,904, 142,788, and 5,207 bottles respectively, each in package sizes of 100. Strict labeling requirements are in place, requiring the offeror to provide the exact drug name and a unique NDC number belonging to the offeror. The contractor's label must be the only label on the product, and affixing labels over existing labels is strictly prohibited. All proposals and documentation are managed electronically via sam.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Veterinary Rabies Vaccine Supplier (IMRAB 3)This subcontract is for the supply of IMRAB 3 veterinary rabies vaccines to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies thimerosal-free, killed virus vaccines that provide three years of protection. All deliverables must adhere to the DLA Master List of Technical and Quality Requirements, comply with DFARS 252.204-7018, and be marked according to Medical Marking Standard No. 1. The opportunity is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance is designated for APO 09227-0000. Interested parties must respond by September 9, 2026, to provide the specified quantity of vaccines meeting all quality and marking standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Oral Rehydration Powder Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Salicylic Acid Plaster Supplier/ManufacturerThis subcontract under the Department of Defense Medical Supply Chain involves the manufacture and supply of Salicylic Acid Plasters for prime contractors on DLA supply contracts. The required product must adhere to NSN 6510-01-120-2643 specifications, featuring a composition of 40 percent salicylic acid and 60 percent base, measuring 5.08 cm by 7.62 cm with a flannel back. The supplier is responsible for managing production to ensure a 24 month shelf life, with no more than 3 months elapsed at the time of delivery. Products must be delivered in packages of 25 plasters each. This opportunity falls under NAICS code 325412 and was posted on September 3, 2026, with a response deadline of September 9, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sumatriptan Succinate Tablets Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Hexagon Head Cap Screw Supply

AVIATION SUPPLY CHAIN ESOC BUYS

POSTED

DEADLINE

Supply of Multivitamin Solution for Injection (NSN 6505-0165-84941)This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of multivitamin solution for injection, identified by NSN 6505-0165-84941. The provider will supply the product configured as two 5 ML vials per 10 ML dose, delivered in sterile vials with accompanying Safety Data Sheets. To qualify, contractors must possess a CAGE code and valid FDA pharmaceutical licensing. A critical component of this contract is the management of cold chain logistics, requiring medical-grade refrigeration to maintain a strict temperature range between 2 and 8 degrees Celsius during both storage and transit. The performance location is designated as FPO 96678, with the response deadline set for September 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Gasket Supply (NSN 5330-01-107-6633)This subcontract under the Department of Defense Land Supply Chain involves the manufacture and supply of 3,321 gaskets meeting NSN 5330-01-107-6633 specifications. The contractor must utilize non-additive manufacturing processes to produce asbestos-free materials, which are to be packaged in medium duty, waterproof, greaseproof, and opaque bags. All deliverables must include full supply chain traceability in accordance with DLAD Procurement Note C03 and MIL-STD-129. The contract is designated as a Total Small Business Set-Aside under NAICS code 325412, with the place of performance located in Cherry Point. The solicitation was posted on September 3, 2026, with a response deadline of September 14, 2026.

LAND SUPPLY CHAIN

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Sodium Chloride Ophthalmic Solution, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Povidone-Iodine Topical Solution SupplierThis subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture and supply of Povidone-Iodine Topical Solution for prime contractors. The supplier must ensure all products conform to USP standards and are delivered with a minimum remaining shelf life of 31 months. All materials must be packaged commercially according to ASTM D3951 standards and delivered in packages of 50 bottles. The supplier is required to certify the domestic origin of the product and its compliance with USP specifications. Performance for this contract is based in San Antonio, Texas, under NAICS code 325412. The response deadline for this opportunity is September 9, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → Department Of The Army -- Usamraa

Same awarding agency

Data Management and Research Sharing Plan DevelopmentThe contract seeks the design and implementation of a secure, compliant data management plan tailored for biomedical research, with a strong emphasis on preserving data integrity, adhering to FAIR principles—findable, accessible, interoperable, and reusable—and meeting federal requirements for data sharing. The plan must ensure that all research data is handled in a manner that supports long-term preservation, ethical use, and regulatory compliance, particularly under Department of Defense standards. The subcontractor will be responsible for developing structured policies and technical workflows that align with evolving federal mandates, enabling seamless data sharing while maintaining rigorous security protocols to protect sensitive biomedical information. The initiative is managed by the Department of the Army through USAMRAA under the broader Department of Defense, with the NAICS code 518210 indicating its focus on data processing and hosting services. The opportunity is open as a subcontract, with responses due by November 4, 2026. While the physical place of performance and point of contact are not specified, the work must be executed to meet federal compliance timelines and deliverables without reliance on proprietary or non-standard frameworks. The goal is to establish a scalable, audit-ready data infrastructure that supports ongoing and future biomedical research initiatives under federal oversight.

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

DEADLINE

in about 2 months

VCA Preservation & Perfusion Modality DevelopmentThis subcontract, titled VCA Preservation and Perfusion Modality Development, supports Defense Health Agency research projects through the Department of the Army USAMRRA. The primary objective is to develop and test strategies for preserving vascularized composite allografts, specifically focusing on implementing active perfusion modalities and static preservation to reduce ischemia-reperfusion injury. The technical execution of the contract requires the use of specialized equipment, including temperature-controlled chambers and perfusion pumps. The successful party is responsible for delivering comprehensive technical reports that detail the efficacy of these methods and provide optimized perfusion protocols.

Measuring, Dispensing, and Other Pumping Equipment Manufacturing

POSTED

DEADLINE

Clinical Graft Monitoring Tool PrototypingThis subcontract opportunity with the Department of the Army USAMRRA involves the development of assays, devices, and technology for clinical graft monitoring in support of Defense Health Agency research projects. The selected provider will prototype monitoring devices and integrate biomarkers into tools specifically designed for the human use factors associated with vascularized composite allotransplantation recipients. The project requires the delivery of a functional prototype or a validated assay kit. To qualify, providers must possess bio-engineering facilities and adhere to ISO 13485 or FDA Quality System Regulation standards. The work falls under NAICS code 541715 and is focused on advancing clinical monitoring capabilities for the Department of Defense.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

VCA Graft Rejection & Immunosuppression Biomarker AnalysisThis subcontract, titled VCA Graft Rejection and Immunosuppression Biomarker Analysis, is issued by the Department of the Army USAMRRA under the Department of Defense. The project focuses on the identification and validation of prognostic or diagnostic biomarkers for prime contractors supporting Defense Health Agency research. The primary scope of work involves analyzing human clinical samples to monitor immunosuppression levels and VCA graft rejection through the use of high-sensitivity assay equipment. To ensure compliance with human subject research standards, the contractor must maintain CLIA certification and obtain IRB approval. The expected deliverables include technical reports, assay results, and validated biomarker profiles. The contract is categorized under NAICS code 621511 and was posted on May 29, 2026.

Medical Laboratories

POSTED

DEADLINE

VCA Clinical Outcome Assessment ToolsThis subcontract, titled VCA Clinical Outcome Assessment Tools, is issued by the Department of the Army USAMRRA under the Department of Defense. The primary objective is to develop tools and metrics to measure the success and functional outcomes of VCA procedures for prime contractors working on Defense Health Agency research projects. This involves the design of both quantitative and qualitative tools specifically focused on quality of life assessments and return-to-duty metrics. The project requires strict adherence to 32 CFR 219.104 regulations regarding human subject research. The final deliverable for this effort is a validated scoring system or outcome measurement tool. The contract is categorized under NAICS code 541712 and was posted on May 29, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

POSTED

DEADLINE

DoW Reconstructive Transplant, Concept Award

Solicitation # HT942526RTRPCA

The fiscal year 2026 Reconstructive Transplant Research Program Concept Award, funding opportunity HT942526RTRPCA, is administered by the Defense Health Agency Contracting Activity to support highly innovative new concepts or untested theories in reconstructive transplantation. This grant program specifically targets creative research that introduces new paradigms or examines existing problems from new perspectives, explicitly excluding clinical trials and incremental advances on published data. Projects must align with at least one FY26 RTRP Focus Area. While preliminary data is not permitted, applicants must provide a strong rationale and demonstrate the ability to achieve interpretable results. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply. The program provides funding capped at 200,000 dollars per award for a maximum period of performance of 18 months, with an estimated total program appropriation of 12 million dollars for FY26. Applications are evaluated through a two-tier process consisting of a peer review for technical merit and a programmatic review for relevance to military health and RTRP priorities. Key submission requirements include a three-page Statement of Work, a one-page Innovation Statement, and a Post-Award Transition Plan. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov. Full applications are due by September 16, 2026, and must adhere to strict PDF naming conventions and disclosure requirements regarding foreign affiliations and regulatory compliance for human or animal subjects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Statistical Analysis and Study DesignThis subcontract opportunity with the Department of the Army USAMRAA involves providing specialized biostatistical expertise to support prime contractors on DHA and DoD research projects. The selected provider will be responsible for developing statistical frameworks for hypotheses, determining sample sizes, and conducting power calculations for behavioral health or biomedical outcomes. Technical proficiency in SAS, R, or SPSS is required to deliver the Statistical Analysis Plan and the Final Data Analysis Report. Qualified candidates must hold an advanced degree in Statistics or Biostatistics to meet the professional requirements of the role. The project falls under NAICS code 541690 and is focused on high-level study design and statistical analysis to ensure the integrity of research outcomes for the Department of Defense.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Clinical Trial Management and CoordinationThis subcontract for Clinical Trial Management and Coordination supports the Department of Defense and the Department of the Army USAMRAA by providing day-to-day management of clinical trials for prime contractors on DHA research projects. The scope of work includes the development and execution of Study Management Plans, the coordination of multi-institutional data transfers, and the management of imaging products and specimen sharing. The contractor is responsible for ensuring all activities adhere to Good Clinical Practice standards and 45 CFR 46.102 using clinical coordinating center infrastructure. Key deliverables for this engagement include the finalized Study Management Plan and comprehensive data transfer logs. The project falls under NAICS code 541714 and was posted on May 21, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Clinical Ethics and Patient AdvocacyThis subcontract, titled Clinical Ethics and Patient Advocacy, supports prime contractors on DHA and DoD research projects by providing essential ethical guidance and patient advocacy. The scope of work includes reviewing study protocols for ethical compliance and developing strategic advice for patient recruitment and retention. Key deliverables consist of Ethics Review Reports and Patient Advocacy Guidance. The position requires specialized qualifications, specifically Clinical Ethicist certification or recognized Patient Advocacy credentials. This effort is managed under the Department of the Army USAMRAA within the Department of Defense, falling under NAICS code 541690.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Regulatory Compliance and Application SupportThe Regulatory Compliance and Application Support subcontract, issued by the Department of the Army under the Department of Defense, focuses on the preparation and submission of regulatory applications for prime contractors involved in DHA and DoD research projects. The scope of work includes managing FDA sponsor applications, ensuring strict adherence to 45 CFR 46.102, and creating clinical monitoring plans designed to mitigate operational risks. To qualify, personnel must possess a Regulatory Affairs Certification or demonstrate equivalent expertise in FDA guidelines. The primary deliverables for this engagement are comprehensive regulatory submission packages and detailed Clinical Monitoring Plans. This effort falls under NAICS code 541690 and is managed through the USAMRAA office.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Clinical Support Tool & Knowledge Product DevelopmentThis subcontract for Clinical Support Tool and Knowledge Product Development supports prime contractors on Defense Health Agency projects through the creation of clinical practice guidelines, provider training materials, and patient-facing tools. The scope of work includes developing patient brochures, scientific journal publications, and medical simulations, all of which must adhere to strict medical publication standards and clinical guideline protocols. The project requires the use of specialized medical writing software and instructional design tools to deliver finalized published guidelines and software applications. This effort is managed under the Department of the Army within the Department of Defense, falling under NAICS code 541511.

Custom Computer Programming Services

POSTED

DEADLINE

Pre-clinical Animal Model TestingThis subcontract for Pre-clinical Animal Model Testing supports the Department of the Army and the Defense Health Agency by conducting animal studies to determine relevance to human orthopaedic biology. The scope of work includes managing specific animal species and strains, performing surgical or therapeutic procedures, and implementing necessary study controls. The selected provider must possess veterinary surgical facilities and animal housing, as well as maintain required IACUC approval and certification. The primary deliverables for this engagement are animal study data and biological impact reports. This effort falls under NAICS code 541720 and is designed to assist prime contractors in validating medical research through rigorous pre-clinical testing.

Research and Development in the Social Sciences and Humanities

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 650+ contractors already using CLEATUS